Chemoradiotherapy: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Chemoradiotherapy

• COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
  NCT05258448 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
  NCT06810609 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 5 locations
• Induction Chemotherapy for Locally Recurrent Rectal Cancer
  NCT04389086 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
  NCT07264647 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
  NCT04913311 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
  NCT03671252 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
  NCT06758830 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Chemoradiotherapy?

7 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.